Arwa Alsamarae, MD
Ophthalmology · Santa Rosa
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 3
- 1 carrier
- Office
- 1
- Since medical school
- 12 years
- Wayne State University School of Medicine, 2014
Offices
1 location · Eye Care Institute A Medical Corporation · 8 clinicians in this group
Looking this up.
Hospitals listed: Adventist Health Ukiah Valley. That is not proof they admit you there this week.
Plans that list them
3 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Alsamarae’s office at (707) 546-9800 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Adventist Health Ukiah ValleyUkiah, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Adventist Health, which runs 28 hospitals in 3 statesPatients rate it 3 of 5 · 66% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Rate of emergency department (ED) visits for patients receiving outpatient chemotherapy: 7.9 (5.8 to 10.5) · 253 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Adventist Health Ukiah Valley
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 0 better, 4 the same, 0 worse of 4 measures. Readmissions: 0 better, 8 the same, 0 worse of 8 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 7.9 (5.8 to 10.5) · 253 cases | Worse | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.92 (0 to 1.95) · 319 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.92 (0.51 to 1.32) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.3 · 38 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.9 · 137 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.4 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.3 · 74 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.7 · 647 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.42) · 2,093 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.29 (0.08 to 0.51) · 2,081 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.64 (2.23 to 7.05) · 328 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 99 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.45 (0.79 to 4.11) · 309 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.96 (0 to 15.74) · 117 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.32 (2.24 to 10.4) · 103 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.67 (0.18 to 3.17) · 119 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.29 (0 to 1.2) · 1,614 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.891 | No different | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.607 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.396 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22 · 114 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -0.9 · 171 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 6.5 · 270 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.1 · 234 cases | None | Jul 2023 – Jun 2025 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.4 (8 to 13.6) · 253 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 37 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.5 (10.4 to 17.4) · 1,320 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.4) · 361 cases | No different | Jan 2024 – Dec 2024 |
What patients said (341 patients answered, 15% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 76% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 75% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 62% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 33% |
| "YES", patients would definitely recommend the hospital | 66% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$444,736
Medicare paid this office $444,736 for 1,093 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Removal of cataract with insertion of prosthetic lens | 119 | $95,444 | $452 |
| Established patient complete exam of visual system | 611 | $64,070 | $99 |
| Established patient problem focused exam of visual system | 555 | $59,966 | $72 |
| Return visit (30+ min) | 320 | $42,358 | $102 |
| Exam of visual field with extended testing | 542 | $39,664 | $54 |
See all 18 services
| Removal of cataract with insertion of prosthetic lens | 119 | $95,444 | $452 |
| Established patient complete exam of visual system | 611 | $64,070 | $99 |
| Established patient problem focused exam of visual system | 555 | $59,966 | $72 |
| Return visit (30+ min) | 320 | $42,358 | $102 |
| Exam of visual field with extended testing | 542 | $39,664 | $54 |
| Removal of recurring cataract in lens capsule using a laser | 76 | $26,939 | $350 |
| Extracapsular removal of cataract with insertion of artificial lens and insertion of drainage device in front chamber of eye | 25 | $21,500 | $614 |
| Imaging of optic nerve | 418 | $13,063 | $29 |
| New patient visit (45+ min) | 115 | $12,087 | $105 |
| Laser repair to improve eye fluid flow | 55 | $11,467 | $201 |
| Measurement of corneal curvature and depth of eye | 190 | $9,838 | $33 |
| Imaging of retina | 225 | $8,395 | $33 |
| New patient complete exam of visual system | 52 | $5,637 | $108 |
| Exam of the internal drainage system of eye | 116 | $2,909 | $23 |
| Exam to measure eye deviation and range of motion | 24 | $1,698 | $57 |
| Ultrasound scan of cornea to determine thickness | 70 | $683 | $9 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 35 | $486 | $14 |
| Removal of eyelashes using forceps | 12 | $216 | $17 |
Procedures Medicare counted
| Cataract surgery | 403 | More than 93% of doctors who do this |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Removal of cataract with insertion of prosthetic lens | 16 | 191 | 334 | 203 | 198 | 211 |
| Removal of recurring cataract in lens capsule using a laser | – | 51 | 46 | 56 | 96 | 77 |
| Laser repair to improve eye fluid flow | – | 12 | 17 | 23 | 39 | 57 |
| Extracapsular removal of cataract with insertion of artificial lens and insertion of drainage device in front chamber of eye | – | – | – | 44 | 62 | 35 |
| Complex removal of cataract with insertion of prosthetic lens | – | 21 | 19 | – | 18 | – |
| Removal of eyelashes using forceps | – | 17 | 18 | – | – | 13 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
1,093 Original Medicare patients in 2024. Average age 77 · Under 65 3% · 85 and older 15% · Women 63% · Also on Medicaid 16% · Health risk score 0.99. At or below the middle of the specialty; the typical ophthalmology clinician is at 1.16.
Conditions among them: High blood pressure 64% · Coronary heart disease 21% · Diabetes 20% · Chronic kidney disease 16% · Atrial fibrillation 15% · Depression 15% · Cancer 14% · Heart failure 11% · COPD 9% · Stroke 6% · Dementia 3%.
The office billed $1,760,885, Medicare allowed $609,612 and paid $444,736; for 4,551 services of 48 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 1,093 | 4,551 | 77 | 0.99 | $1,760,885 | $444,736 |
| 2023 | 1,051 | 4,221 | 77 | 0.97 | $1,746,180 | $423,093 |
| 2022 | 1,020 | 3,780 | 76 | 0.96 | $1,528,439 | $366,792 |
| 2021 | 945 | 3,430 | 76 | 1.03 | $1,652,885 | $391,654 |
| 2020 | 957 | 2,954 | 75 | 1.07 | $1,193,093 | $290,987 |
| 2019 | 368 | 733 | 76 | 1.14 | $275,867 | $58,415 |
| 2018 | 62 | 91 | 76 | 1.04 | $151,101 | $7,384 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 18 services
| Removal of cataract with insertion of prosthetic lens | 120 | $88,639 | $448 |
| Established patient problem focused exam of visual system | 551 | $60,272 | $70 |
| Established patient complete exam of visual system | 562 | $55,952 | $96 |
| Extracapsular removal of cataract with insertion of artificial lens and insertion of drainage device in front chamber of eye | 45 | $34,726 | $560 |
| Removal of recurring cataract in lens capsule using a laser | 94 | $32,796 | $342 |
| Return visit (30+ min) | 274 | $31,611 | $93 |
| Exam of visual field with extended testing | 489 | $30,046 | $51 |
| Imaging of optic nerve | 415 | $12,287 | $28 |
| Complex removal of cataract with insertion of prosthetic lens | 14 | $11,057 | $614 |
| Measurement of corneal curvature and depth of eye | 182 | $9,065 | $32 |
| Laser repair to improve eye fluid flow | 37 | $8,325 | $213 |
| New patient complete exam of visual system | 72 | $7,773 | $108 |
| New patient visit (45+ min) | 70 | $7,636 | $109 |
| Imaging of retina | 162 | $6,502 | $33 |
| Exam of the internal drainage system of eye | 146 | $3,639 | $24 |
| New patient problem focused exam of visual system | 19 | $1,352 | $71 |
| Exam to measure eye deviation and range of motion | 17 | $1,267 | $53 |
| Ultrasound scan of cornea to determine thickness | 105 | $989 | $9 |
2022: 16 services
| Removal of cataract with insertion of prosthetic lens | 119 | $90,159 | $444 |
| Established patient problem focused exam of visual system | 472 | $59,709 | $71 |
| Established patient complete exam of visual system | 547 | $51,406 | $91 |
| Return visit (30+ min) | 198 | $27,040 | $95 |
| Extracapsular removal of cataract with insertion of artificial lens and insertion of drainage device in front chamber of eye | 28 | $25,502 | $580 |
| Exam of visual field with extended testing | 376 | $24,871 | $52 |
| Removal of recurring cataract in lens capsule using a laser | 54 | $16,657 | $297 |
| New patient visit (45+ min) | 90 | $10,225 | $114 |
| Imaging of optic nerve | 330 | $9,549 | $28 |
| Measurement of corneal curvature and depth of eye | 196 | $9,213 | $33 |
| New patient complete exam of visual system | 72 | $7,148 | $99 |
| Imaging of retina | 155 | $5,836 | $32 |
| Laser repair to improve eye fluid flow | 23 | $4,560 | $198 |
| Exam of the internal drainage system of eye | 119 | $2,965 | $24 |
| New patient problem focused exam of visual system | 21 | $1,394 | $66 |
| Ultrasound scan of cornea to determine thickness | 72 | $666 | $9 |
2021: 21 services
| Removal of cataract with insertion of prosthetic lens | 196 | $155,422 | $465 |
| Established patient problem focused exam of visual system | 442 | $58,071 | $73 |
| Established patient complete exam of visual system | 441 | $42,607 | $91 |
| Exam of visual field with extended testing | 295 | $18,158 | $54 |
| Return visit (30+ min) | 136 | $17,597 | $99 |
| Removal of recurring cataract in lens capsule using a laser | 42 | $13,326 | $290 |
| Internal insertion of eye fluid drainage device | 30 | $13,012 | $289 |
| Complex removal of cataract with insertion of prosthetic lens | 14 | $12,012 | $632 |
| New patient complete exam of visual system | 114 | $11,093 | $97 |
| Measurement of corneal curvature and depth of eye | 209 | $11,073 | $35 |
| Imaging of optic nerve | 255 | $7,694 | $29 |
| New patient visit (45+ min) | 53 | $5,017 | $95 |
| Imaging of retina | 105 | $4,285 | $33 |
| Laser repair to improve eye fluid flow | 16 | $3,760 | $221 |
| Exam of the internal drainage system of eye | 100 | $2,558 | $25 |
| Ct scan of cornea | 36 | $1,087 | $30 |
| New patient problem focused exam of visual system | 19 | $1,036 | $55 |
| Exam to measure eye deviation and range of motion | 11 | $929 | $55 |
| Ultrasound scan of cornea to determine thickness | 65 | $629 | $10 |
| Ultrasound scan to determine eye length and lens power | 11 | $504 | $42 |
| Removal of eyelashes using forceps | 16 | $281 | $16 |
2020: 20 services
| Removal of cataract with insertion of prosthetic lens | 115 | $86,800 | $454 |
| Established patient problem focused exam of visual system | 377 | $47,897 | $70 |
| Established patient complete exam of visual system | 472 | $45,808 | $91 |
| New patient complete exam of visual system | 192 | $17,678 | $92 |
| Removal of recurring cataract in lens capsule using a laser | 50 | $15,298 | $300 |
| Exam of visual field with extended testing | 220 | $13,412 | $51 |
| Complex removal of cataract with insertion of prosthetic lens | 16 | $12,411 | $591 |
| Measurement of corneal curvature and depth of eye | 177 | $10,781 | $43 |
| Imaging of optic nerve | 192 | $5,899 | $29 |
| Internal insertion of eye fluid drainage device | 14 | $5,012 | $264 |
| Imaging of retina | 131 | $4,628 | $32 |
| New patient problem focused exam of visual system | 54 | $2,969 | $55 |
| Laser repair to improve eye fluid flow | 12 | $2,612 | $218 |
| Exam of the internal drainage system of eye | 108 | $2,551 | $23 |
| Closure of tear duct opening using plug | 12 | $2,187 | $95 |
| Short return visit (20+ min) | 27 | $1,707 | $59 |
| Return visit (30+ min) | 22 | $1,266 | $58 |
| Ct scan of cornea | 34 | $995 | $29 |
| Ultrasound scan of cornea to determine thickness | 58 | $543 | $9 |
| Removal of eyelashes using forceps | 16 | $378 | $22 |
2019: 16 services
| Established patient complete exam of visual system | 115 | $12,206 | $103 |
| Established patient problem focused exam of visual system | 98 | $9,015 | $75 |
| Removal of cataract with insertion of prosthetic lens | 11 | $8,715 | $545 |
| New patient complete exam of visual system | 48 | $5,385 | $112 |
| Established patient problem focused exam of visual system | 62 | $2,398 | $36 |
| Measurement of corneal curvature and depth of eye | 34 | $2,308 | $54 |
| Exam of visual field with extended testing | 38 | $2,059 | $51 |
| Imaging of optic nerve | 42 | $1,248 | $30 |
| Imaging of retina | 31 | $1,098 | $34 |
| Exam of the internal drainage system of eye | 38 | $946 | $24 |
| New patient problem focused exam of visual system | 13 | $871 | $67 |
| Established patient complete exam of visual system | 12 | $685 | $57 |
| Exam of visual field with extended testing | 37 | $668 | $18 |
| Internal insertion of eye fluid drainage device | 12 | $486 | $35 |
| Imaging of optic nerve | 17 | $243 | $14 |
| Ultrasound scan of cornea to determine thickness | 18 | $173 | $10 |
2018: 2 services
| Established patient problem focused exam of visual system | 19 | $952 | $41 |
| Internal insertion of eye fluid drainage device | 11 | $389 | $26 |
Medicaid work
$20,553 in 2024
Medicaid paid $20,553 for 644 billed services this clinician did in 2024, up to 29 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 218 | $7,561 |
| Visual field examination, unilateral or bilateral, with interpretation and report; extended examination (eg, Goldmann visual fields with at least 3 isopters plotted and static determination within the central 30°, or quantitative, automated threshold perimetry, Octopus program G-1, 32 or 42, Humphrey visual field analyzer full threshold programs 30-2, 24-2, or 30/60-2) | 184 | $5,123 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; optic nerve | 91 | $2,750 |
| Return visit (30+ min) | 67 | $2,393 |
| Ophthalmic biometry by partial coherence interferometry with intraocular lens power calculation | 44 | $2,172 |
| DETERMINATION REFRACTIVE STATE | 25 | $308 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 15 | $246 |
| 2024 | 644 | 7 | 29 | $20,553 |
| 2023 | 620 | 8 | 26 | $17,208 |
| 2022 | 302 | 5 | 19 | $10,323 |
| 2021 | 225 | 3 | 21 | $6,963 |
| 2020 | 283 | 5 | 24 | $10,378 |
| 2019 | 21 | 1 | 19 | $805 |
See the largest Medicaid services in earlier years
2023
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 234 | $7,510 |
| Visual field examination, unilateral or bilateral, with interpretation and report; extended examination (eg, Goldmann visual fields with at least 3 isopters plotted and static determination within the central 30°, or quantitative, automated threshold perimetry, Octopus program G-1, 32 or 42, Humphrey visual field analyzer full threshold programs 30-2, 24-2, or 30/60-2) | 156 | $3,572 |
| Return visit (30+ min) | 61 | $2,400 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; optic nerve | 62 | $1,760 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 51 | $922 |
| GONIOSCOPY | 25 | $443 |
| Ophthalmic biometry by partial coherence interferometry with intraocular lens power calculation | 13 | $370 |
| DETERMINATION REFRACTIVE STATE | 18 | $231 |
2022
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 189 | $6,955 |
| Return visit (30+ min) | 31 | $1,302 |
| Visual field examination, unilateral or bilateral, with interpretation and report; extended examination (eg, Goldmann visual fields with at least 3 isopters plotted and static determination within the central 30°, or quantitative, automated threshold perimetry, Octopus program G-1, 32 or 42, Humphrey visual field analyzer full threshold programs 30-2, 24-2, or 30/60-2) | 41 | $794 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 29 | $676 |
| Ophthalmic biometry by partial coherence interferometry with intraocular lens power calculation | 12 | $596 |
2021
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 185 | $5,614 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 27 | $861 |
| Visual field examination, unilateral or bilateral, with interpretation and report; extended examination (eg, Goldmann visual fields with at least 3 isopters plotted and static determination within the central 30°, or quantitative, automated threshold perimetry, Octopus program G-1, 32 or 42, Humphrey visual field analyzer full threshold programs 30-2, 24-2, or 30/60-2) | 13 | $488 |
2020
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 199 | $7,196 |
| OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST | 32 | $1,625 |
| Visual field examination, unilateral or bilateral, with interpretation and report; extended examination (eg, Goldmann visual fields with at least 3 isopters plotted and static determination within the central 30°, or quantitative, automated threshold perimetry, Octopus program G-1, 32 or 42, Humphrey visual field analyzer full threshold programs 30-2, 24-2, or 30/60-2) | 26 | $928 |
| Ophthalmic biometry by partial coherence interferometry with intraocular lens power calculation | 13 | $322 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 13 | $307 |
2019
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 21 | $805 |
Drugs they prescribed that Part D paid
$431,856
Pharmacies billed $431,856 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 3,018) in 2024. At or below the middle of the specialty; the typical ophthalmology clinician is at 0%.
1,626 generic and 1,392 brand-name prescriptions · $431,856 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Rocklatan | 133 | $86,621 | $651 |
| Rhopressa | 127 | $75,782 | $597 |
| Restasis | 40 | $55,352 | $1,384 |
| Lumigan | 68 | $37,068 | $545 |
| Cyclosporine | 33 | $18,114 | $549 |
See all 27 drugs
| Rocklatan | 133 | $86,621 | $651 |
| Rhopressa | 127 | $75,782 | $597 |
| Restasis | 40 | $55,352 | $1,384 |
| Lumigan | 68 | $37,068 | $545 |
| Cyclosporine | 33 | $18,114 | $549 |
| Prednisolone Acetate | 342 | $17,660 | $52 |
| Latanoprost | 894 | $14,612 | $16 |
| Simbrinza | 26 | $13,462 | $518 |
| Vyzulta | 22 | $12,981 | $590 |
| Xiidra | 11 | $11,599 | $1,054 |
| Tafluprost | 28 | $9,833 | $351 |
| Alphagan P | 23 | $9,521 | $414 |
| Combigan | 19 | $8,455 | $445 |
| Brimonidine Tartrate-Timolol | 33 | $6,030 | $183 |
| Brinzolamide | 23 | $5,601 | $244 |
| Dorzolamide-Timolol | 270 | $4,950 | $18 |
| Travoprost | 28 | $4,459 | $159 |
| Brimonidine | 211 | $3,558 | $17 |
| Timolol Maleate | 288 | $3,356 | $12 |
| Dorzolamide-Timolol | 20 | $2,994 | $150 |
| Dorzolamide | 104 | $2,126 | $20 |
| Diclofenac | 76 | $682 | $9 |
| Acyclovir | 13 | $680 | $52 |
| Neomycin-Polymyxin-Dexameth | 41 | $462 | $11 |
| Moxifloxacin | 16 | $303 | $19 |
| Ofloxacin | 16 | $200 | $12 |
| Erythromycin | 18 | $164 | $9 |
Year by year
| 2024 | 3,018 | 749 | 0% (0) | 46% | $431,856 |
| 2023 | 2,535 | 659 | 0% (0) | 49% | $473,475 |
| 2022 | 2,411 | 623 | 0% (0) | 52% | $472,887 |
| 2021 | 1,755 | 498 | 0% (0) | 56% | $262,259 |
| 2020 | 973 | 338 | 0% (0) | 52% | $118,020 |
| 2019 | 737 | 224 | 0% (0) | 37% | $57,856 |
| 2018 | 903 | 233 | 0% (0) | 39% | $64,106 |
| 2017 | 689 | 155 | 0% (0) | 42% | $45,109 |
| 2016 | 210 | 76 | None | 33% | $16,139 |
| 2015 | 160 | 80 | None | 22% | $8,367 |
| 2014 | 13 | None | None | None | $322 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 27 drugs
| Rocklatan | 122 | $93,644 | $768 |
| Rhopressa | 118 | $85,290 | $723 |
| Lumigan | 58 | $40,708 | $702 |
| Restasis | 25 | $39,416 | $1,577 |
| Xiidra | 16 | $22,672 | $1,417 |
| Latanoprost | 704 | $22,247 | $32 |
| Prednisolone Acetate | 291 | $16,685 | $57 |
| Cequa | 13 | $16,438 | $1,264 |
| Simbrinza | 29 | $14,898 | $514 |
| Combigan | 33 | $13,508 | $409 |
| Brimonidine Tartrate-Timolol | 23 | $12,801 | $557 |
| Cyclosporine | 11 | $10,444 | $949 |
| Dorzolamide-Timolol | 236 | $8,465 | $36 |
| Alphagan P | 16 | $7,322 | $458 |
| Dorzolamide-Timolol | 19 | $6,145 | $323 |
| Brinzolamide | 23 | $6,088 | $265 |
| Tafluprost | 14 | $5,881 | $420 |
| Travoprost | 26 | $5,875 | $226 |
| Timolol Maleate | 292 | $5,416 | $19 |
| Zioptan | 14 | $5,025 | $359 |
| Brimonidine | 151 | $4,193 | $28 |
| Dorzolamide | 75 | $2,512 | $33 |
| Difluprednate | 11 | $2,137 | $194 |
| Diclofenac | 62 | $716 | $12 |
| Neomycin-Polymyxin-Dexameth | 36 | $481 | $13 |
| Acyclovir | 11 | $400 | $36 |
| Erythromycin | 14 | $180 | $13 |
2022: 24 drugs
| Rocklatan | 126 | $90,344 | $717 |
| Rhopressa | 141 | $89,522 | $635 |
| Restasis | 37 | $60,488 | $1,635 |
| Lumigan | 94 | $58,426 | $622 |
| Latanoprost | 617 | $22,013 | $36 |
| Cequa | 19 | $20,246 | $1,066 |
| Prednisolone Acetate | 285 | $17,080 | $60 |
| Combigan | 30 | $15,076 | $503 |
| Simbrinza | 33 | $9,855 | $299 |
| Zioptan | 25 | $9,456 | $378 |
| Alphagan P | 18 | $9,346 | $519 |
| Brinzolamide | 17 | $8,252 | $485 |
| Dorzolamide-Timolol | 211 | $7,437 | $35 |
| Brimonidine | 155 | $5,422 | $35 |
| Travoprost | 15 | $4,912 | $327 |
| Brimonidine Tartrate-Timolol | 12 | $3,842 | $320 |
| Timolol Maleate | 212 | $3,831 | $18 |
| Dorzolamide-Timolol | 23 | $3,148 | $137 |
| Dorzolamide | 81 | $2,682 | $33 |
| Neomycin-Polymyxin-Dexameth | 51 | $882 | $17 |
| Valacyclovir | 14 | $778 | $56 |
| Erythromycin | 28 | $338 | $12 |
| Diclofenac | 22 | $273 | $12 |
| Ofloxacin | 13 | $226 | $17 |
2021: 19 drugs
| Rhopressa | 125 | $54,805 | $438 |
| Rocklatan | 70 | $40,024 | $572 |
| Lumigan | 64 | $35,428 | $554 |
| Prednisolone Acetate | 276 | $18,701 | $68 |
| Combigan | 28 | $14,540 | $519 |
| Latanoprost | 420 | $13,888 | $33 |
| Alphagan P | 21 | $9,950 | $474 |
| Travoprost | 27 | $6,918 | $256 |
| Dorzolamide-Timolol | 149 | $5,560 | $37 |
| Brimonidine | 87 | $5,226 | $60 |
| Zioptan | 14 | $5,090 | $364 |
| Dorzolamide-Timolol | 29 | $5,085 | $175 |
| Timolol Maleate | 156 | $3,744 | $24 |
| Simbrinza | 15 | $2,860 | $191 |
| Dorzolamide | 38 | $1,440 | $38 |
| Neomycin-Polymyxin-Dexameth | 48 | $787 | $16 |
| Diclofenac | 30 | $423 | $14 |
| Erythromycin | 17 | $205 | $12 |
| Ofloxacin | 14 | $195 | $14 |
2020: 15 drugs
| Lumigan | 33 | $18,838 | $571 |
| Rhopressa | 35 | $14,673 | $419 |
| Combigan | 29 | $12,288 | $424 |
| Prednisolone Acetate | 177 | $10,681 | $60 |
| Alphagan P | 21 | $8,317 | $396 |
| Rocklatan | 16 | $7,586 | $474 |
| Latanoprost | 202 | $5,609 | $28 |
| Travoprost | 16 | $3,743 | $234 |
| Dorzolamide-Timolol | 74 | $3,374 | $46 |
| Brimonidine | 58 | $2,803 | $48 |
| Dorzolamide | 38 | $1,368 | $36 |
| Timolol Maleate | 77 | $1,037 | $13 |
| Neomycin-Polymyxin-Dexameth | 36 | $631 | $18 |
| Erythromycin | 25 | $313 | $13 |
| Diclofenac | 14 | $300 | $21 |
2019: 13 drugs
| Lumigan | 15 | $7,855 | $524 |
| Combigan | 21 | $5,634 | $268 |
| Latanoprost | 247 | $5,329 | $22 |
| Travatan Z | 18 | $4,745 | $264 |
| Alphagan P | 18 | $3,750 | $208 |
| Prednisolone Acetate | 69 | $3,383 | $49 |
| Dorzolamide-Timolol | 59 | $3,061 | $52 |
| Brimonidine | 62 | $2,204 | $36 |
| Dorzolamide | 35 | $1,518 | $43 |
| Ketorolac Tromethamine | 28 | $1,219 | $44 |
| Timolol Maleate | 60 | $1,085 | $18 |
| Ofloxacin | 15 | $258 | $17 |
| Erythromycin | 11 | $148 | $13 |
2018: 12 drugs
| Combigan | 47 | $14,889 | $317 |
| Azopt | 37 | $12,893 | $348 |
| Alphagan P | 28 | $7,691 | $275 |
| Prednisolone Acetate | 88 | $4,937 | $56 |
| Latanoprost | 301 | $4,927 | $16 |
| Brimonidine | 97 | $3,616 | $37 |
| Ketorolac Tromethamine | 48 | $2,176 | $45 |
| Timolol Maleate | 73 | $1,466 | $20 |
| Acetazolamide | 19 | $1,172 | $62 |
| Moxifloxacin | 19 | $1,044 | $55 |
| Dorzolamide-Timolol | 37 | $994 | $27 |
| Dorzolamide | 50 | $878 | $18 |
2017: 11 drugs
| Brimonidine | 77 | $7,715 | $100 |
| Azopt | 23 | $7,639 | $332 |
| Prednisolone Acetate | 66 | $4,547 | $69 |
| Alphagan P | 14 | $4,417 | $316 |
| Combigan | 15 | $3,579 | $239 |
| Latanoprost | 240 | $3,299 | $14 |
| Timolol Maleate | 43 | $2,574 | $60 |
| Ketorolac Tromethamine | 39 | $1,727 | $44 |
| Dorzolamide-Timolol | 63 | $1,410 | $22 |
| Moxifloxacin | 19 | $1,320 | $69 |
| Dorzolamide | 21 | $373 | $18 |
2016: 5 drugs
| Brimonidine | 25 | $4,063 | $163 |
| Prednisolone Acetate | 18 | $1,238 | $69 |
| Latanoprost | 70 | $956 | $14 |
| Dorzolamide-Timolol | 32 | $678 | $21 |
| Timolol Maleate | 12 | $301 | $25 |
2015: 2 drugs
| Latanoprost | 22 | $360 | $16 |
| Erythromycin | 11 | $160 | $15 |
Money from drug and device companies
$130 in 2025
| 2025 | 3 | 6 | None | $130 |
| 2024 | 5 | 7 | None | $142 |
| 2023 | 5 | 7 | None | $154 |
| 2022 | 4 | 9 | None | $199 |
| 2021 | 3 | 9 | None | $326 |
| 2020 | 2 | 2 | None | $38 |
| 2019 | 2 | 2 | None | $39 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Alcon Vision | Rocklatan | $77 | 3 payments
|
| Abbvie | Lumigan | $38 | 2 payments
|
| Bausch & Lomb Americas | Vyzulta | $15 | 1 payment
|
See all 6 published payments
| Alcon Vision | Meals · 2025-12-05 | Rocklatan | $19 |
| Abbvie | Meals · 2025-09-23 | Lumigan | $18 |
| Bausch & Lomb Americas | Meals · 2025-08-21 | Vyzulta | $15 |
| Alcon Vision | Meals · 2025-08-19 | Rocklatan | $26 |
| Alcon Vision | Meals · 2025-05-31 | Clareon | $32 |
| Abbvie | Meals · 2025-03-18 | Lumigan | $20 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $142
| Alcon Vision | Rocklatan | $66 | 3 payments
|
| Amgen | Tepezza | $22 | 1 payment
|
| Johnson & Johnson Surgical Vision | Tecnis Simplicity | $20 | 1 payment
|
| Biotissue Holdings | None | $18 | 1 payment
|
| Bausch & Lomb Americas | Vyzulta | $15 | 1 payment
|
2023: $154
| Alcon Vision | Clareon | $59 | 3 payments
|
| Oyster Point Pharma | Tyrvaya | $30 | 1 payment
|
| Thea Pharma | Iyuzeh | $24 | 1 payment
|
| Horizon Therapeutics plc | Tepezza | $24 | 1 payment
|
| Sun Pharmaceutical Industries | Cequa | $17 | 1 payment
|
2022: $199
| Alcon Vision | Simbrinza | $119 | 6 payments
|
| BioTissue Holdings | Prokera | $50 | 1 payment
|
| Bausch & Lomb Americas | Vyzulta | $19 | 1 payment
|
| Novartis Pharmaceuticals | Xiidra | $12 | 1 payment
|
2021: $326
| Alcon Vision | Acrysof Iq Vivity Iol | $207 | 5 payments
|
| Aerie Pharmaceuticals | Rocklatan | $84 | 2 payments
|
| Allergan | Xen Glaucoma Treatment System | $35 | 2 payments
|
2020: $38
| Aerie Pharmaceuticals | Rhopressa | $19 | 1 payment
|
| Novartis Pharmaceuticals | Xiidra | $19 | 1 payment
|
2019: $39
| Alcon Vision | Centurion | $26 | 1 payment
|
| Sight Sciences | Omni | $14 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 94.7 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1487072534
- Licence
- MI 4301105342
- Trained
- Wayne State University School of Medicine, 2014 · 12 years ago
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207W00000X (207W00000X)
- Mailing address
- 3035 Cleveland Ave Ste 100, Santa Rosa, CA, 95403
- NPI first listed
- 2014-04-04
- NPI last updated
- 2026-01-05
- NPI record certified
- 2026-01-05
This is when the NPI record was last certified, not a medical board exam.